Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9413724Aexternal-prioritypatent/GB9413724D0/en
Application filed by IndividualfiledCriticalIndividual
Publication of CA2193665A1publicationCriticalpatent/CA2193665A1/fr
Application grantedgrantedCritical
Publication of CA2193665CpublicationCriticalpatent/CA2193665C/fr
Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
Use of 2-methylamino-2-phenyl-cyclohexanone for preparing pharmaceutical compositions against bacterial-, funga, viral or protozoal infections and having immunomodulator effect